VEGFA has been identified as a biomarker for a number of metabolic diseases due to its involvement in insulin secretion and the regulation of metabolic responses in type 2 diabetes (T2DM) [13,14,15]. This evidence concerns the gene VEGFA and type 2 diabetes mellitus.